FDA label
What is meprobamate used for?
The FDA-approved uses of meprobamate, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted meprobamate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Meprobamate, tablet
Indications and Usage, quoted from the label by Cipla USA Inc. (ANDA040797). Cross-references to other label sections are left out.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is,more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Source: DailyMed label, set id 17d814e2-b277-4dce-8615-e7fd7cab773f, version 2, effective July 8, 2026. NDC 69097-974, one of 6 listings for this product.
Questions
What is meprobamate used for?
The FDA label says: “Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Meprobamate
- Is Meprobamate a controlled substance?Schedule IV
- Generic for EquanilFDA Orange Book
- Generic for MepriamFDA Orange Book
- Generic for MiltownFDA Orange Book
- Generic for NeuramateFDA Orange Book
- Generic for TranmepFDA Orange Book
- NDC 46708-019Meprobamate NDC record
- NDC 46708-020Meprobamate NDC record
- NDC 62332-019Meprobamate NDC record
- Schedule IV drugs listDEA schedule